» Articles » PMID: 17205078

Bcl-2 Family Proteins Are Essential for Platelet Survival

Overview
Specialty Cell Biology
Date 2007 Jan 6
PMID 17205078
Citations 194
Authors
Affiliations
Soon will be listed here.
Abstract

Platelets are relatively short-lived, anucleated cells that are essential for proper hemostasis. The regulation of platelet survival in the circulation remains poorly understood. The process of platelet activation and senescence in vivo is associated with processes similar to those observed during apoptosis in nucleated cells, including loss of mitochondrial membrane potential, caspase activation, phosphatidylserine (PS) externalization, and cell shrinkage. ABT-737, a potent antagonist of Bcl-2, Bcl-X(L), and Bcl-w, induces apoptosis in nucleated cells dependent on these proteins for survival. In vivo, ABT-737 induces a reduction of circulating platelets that is maintained during drug therapy, followed by recovery to normal levels within several days after treatment cessation. Whole body scintography utilizing ([111])Indium-labeled platelets in dogs shows that ABT-737-induced platelet clearance is primarily mediated by the liver. In vitro, ABT-737 treatment leads to activation of key apoptotic processes including cytochrome c release, caspase-3 activation, and PS externalization in isolated platelets. Despite these changes, ABT-737 is ineffective in promoting platelet activation as measured by granule release markers and platelet aggregation. Taken together, these data suggest that ABT-737 induces an apoptosis-like response in platelets that is distinct from platelet activation and results in enhanced clearance in vivo by the reticuloendothelial system.

Citing Articles

A novel technique to characterize procoagulant platelet formation and evaluate platelet procoagulant tendency in cats by flow cytometry.

Shaverdian M, Nguyen N, Li R Front Vet Sci. 2025; 11:1480756.

PMID: 39742312 PMC: 11685743. DOI: 10.3389/fvets.2024.1480756.


Unlocking the Potential of Senolytic Compounds: Advancements, Opportunities, and Challenges in Ageing-Related Research.

Gomez L, Jurk D Subcell Biochem. 2024; 107:91-116.

PMID: 39693021 DOI: 10.1007/978-3-031-66768-8_5.


Desialylation and Apoptosis in Immune Thrombocytopenia: Implications for Pathogenesis and Treatment.

Zheng S, Perdomo J Curr Issues Mol Biol. 2024; 46(11):11942-11956.

PMID: 39590303 PMC: 11592706. DOI: 10.3390/cimb46110709.


Integrated molecular and functional characterization of the intrinsic apoptotic machinery identifies therapeutic vulnerabilities in glioma.

Fernandez E, Mai W, Song K, Bayley N, Kim J, Zhu H Nat Commun. 2024; 15(1):10089.

PMID: 39572533 PMC: 11582606. DOI: 10.1038/s41467-024-54138-9.


BCL-X-targeting antibody-drug conjugates are active in preclinical models and mitigate on-mechanism toxicity of small-molecule inhibitors.

Judd A, Bawa B, Buck W, Tao Z, Li Y, Mitten M Sci Adv. 2024; 10(40):eado7120.

PMID: 39365864 PMC: 11451551. DOI: 10.1126/sciadv.ado7120.